Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Southern Acids (M) Bhd's average EBITDA Per Share Growth Rate was 24.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 1.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -2.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 6.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Southern Acids (M) Bhd was 47.40% per year. The lowest was -16.80% per year. And the median was 3.75% per year.
Southern Acids (M) Bhd (XKLS:5134) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Southern Acids (M) Bhd 5-Year EBITDA Growth Rate Related Terms
XKLS:5134 vs MMM, HON: 5-Year EBITDA Growth Rate Comparison
For the Conglomerates subindustry, Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd 5-Year EBITDA Growth Rate vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate falls into.
Southern Acids (M) Bhd 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of -2.40% mean?
Southern Acids (M) Bhd (XKLS:5134) has a 5-Year EBITDA Growth Rate of -2.40% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate too high?
Southern Acids (M) Bhd's current 5-Year EBITDA Growth Rate is -2.40%. Overall, Southern Acids (M) Bhd has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate compare to MMM and HON?
Southern Acids (M) Bhd's 5-Year EBITDA Growth Rate of -2.40% can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Conglomerates company?
A good 5-Year EBITDA Growth Rate depends on the Conglomerates industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current 5-Year EBITDA Growth Rate is -2.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM3.00, compared to a current price of RM3.14 — trading 4.7% above its estimated fair value. The current 5-Year EBITDA Growth Rate is -2.40%. Southern Acids (M) Bhd's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current 5-Year EBITDA Growth Rate is -2.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.14 is trading 4.7% above its estimated GF Value™ of RM3.00.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
5-Year EBITDA Growth Rate: -2.40%
GF Value™: RM3.00 vs. price of RM3.14 (4.7% above fair value)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
67GF Score
Get the complete analysis for XKLS:5134
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
